BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:13 PM
 | 
Jun 26, 2007
 |  BC Extra  |  Clinical News

MediciNova refocuses pipeline

MediciNova (MNOV; Osaka:4875) will discontinue development of MN-001 in its current immediate release formulation, which requires multiple doses per day, and instead develop a once-daily formulation. The IR version of the leukotriene receptor antagonist and inhibitor of PDE-4,...

Read the full 177 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >